Enlivex Therapeutics Institutional Ownership

+0.13 (+1.31 %)
(As of 05/7/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume56,700 shs
Average Volume366,259 shs
Market Capitalization$158.23 million
P/E RatioN/A
Dividend YieldN/A

Institutional Ownership

Institutional Ownership Changes (13F Filings) for Enlivex Therapeutics (NASDAQ:ENLV)

Institutional Ownership Percentage: 2.39%

Institutional Buying and Selling by Quarter

Enlivex Therapeutics (NASDAQ ENLV) Institutional Buying and Selling

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in Company
4/23/2021Compagnie Lombard Odier SCmA25,000$0.27M0.0%N/A0.159%
4/13/2021Golden Green Inc.69,782$0.77M0.7%+51.5%0.443%
2/10/2021Renaissance Technologies LLC279,106$2.35M0.0%-6.5%2.073%
1/25/2021Golden Green Inc.46,056$0.39M0.4%N/A0.342%
11/17/2020Jane Street Group LLC10,807$64K0.0%-64.8%0.080%
9/15/2020Two Sigma Advisers LP10,100$51K0.0%N/A0.075%
8/17/2020Jane Street Group LLC30,711$0.16M0.0%N/A0.229%
8/14/2020Sabby Management LLC12,925$65K0.0%-97.1%0.096%
5/15/2020Sabby Management LLC445,673$2.09M0.9%N/A3.319%
5/15/2020Morgan Stanley28,149$0.13M0.0%+1,407,350.0%0.210%
2/13/2020Renaissance Technologies LLC38,390$0.32M0.0%+61.4%0.371%
1/31/2020ARK Investment Management LLC38,536$0.32M0.0%N/A0.373%
(Data available from 1/1/2016 forward)

This page was last updated on 5/10/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.